<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240928063187N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-22</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effects of mouthwash and in situ gel containing benzydamine hydrochloride in the management of oral mucositis</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effects of mouthwash and in situ gel containing benzydamine hydrochloride in the management of radiotherapy-induced oral mucositis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>92</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87221</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Patients will be distributed into two groups using an online randomization program. In this study, block randomization is used to allocate eligible individuals in a 1:1 ratio to treatment groups (A, B). The block size is 4, and a total of 23 blocks are considered. Each block contains an equal number of interventions. PASS 2021 software is used to generate random sequences in blocks. The sealed envelope method is used to conceal the randomization sequence. An independent biostatistician in this study will generate the randomization sequence, and then the generated random codes will be placed in the envelope and sealed, and the researchers of this study will be unaware of the treatment type. Eligible individuals will be referred in order and included in the study according to the randomization sequence and sealed envelopes. The treatment will be prepared as treatment A or B by the pharmacist according to the randomization sequence.</study_design>
      <phase>3</phase>
      <hc_freetext>mucusitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Mucoadhesive gel in the form of a spray, which is sprayed on the mucosa every 8 hours (3 times a day), was developed by the dental materials team of Shahid Beheshti Dental Clinic. For two weeks. Intervention 2: Control group: Benzydamine mouthwash (0.15%) available on the market from Elixir Pharmaceutical Company (Benzylazine), measuring cups (5 to 15 ml), for two weeks, every 8 hours (3 times a day).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Comparison of the effects of mouthwash and mucoadhesive gel containing benzydamine hydrochloride in the management of radiotherapy-induced oral mucositis

When:
starting 6 months after publication

To whom:
Everyone has access.

Conditions:
There are no special conditions.

Where to obtain:
Via email address

How to obtain:
Request via email address only.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Owlia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Deha Fajr Boulevard, Imam Reza Street, Faculty of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3867765178</zip>
        <telephone>+98 35 3620 4760</telephone>
        <email>f.owlia@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Owlia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Deha Fajr Boulevard, Imam Reza Street, Faculty of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3867765178</zip>
        <telephone>+98 35 3620 4760</telephone>
        <email>f.owlia@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over 18 years of age with head and neck cancer who require radiation therapy with a dose of at least 60 Gy.
Willingness to participate in the study
Have the ability to rinse and gargle
They have no smoking during radiotherapy.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1) Patients with any source of infection in the mouth
2) Patients using dentures
3) History of allergy to chitosan or benzydamine
4) Patients with a history of previous cancer treatment.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Mucoadhesive gel in the form of a spray, which is sprayed on the mucosa every 8 hours (3 times a day), was developed by the dental materials team of Shahid Beheshti Dental Clinic. For two weeks</i_keyword>
      <i_keyword>Control group: Benzydamine mouthwash (0.15%) available on the market from Elixir Pharmaceutical Company (Benzylazine), measuring cups (5 to 15 ml), for two weeks, every 8 hours (3 times a day)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Determining and comparing the pain level of oral mucositis caused by radiotherapy in cancer patients before and after intervention in the mouthwash and mucoadhesive gel groups containing benzydamine. Timepoint: Follow-up will be conducted for 2 weeks and in 4 sessions (days 3, 5, 7 and 14). Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>تعیین و مقایسه شدت موکوز دهانی گروه ناشی از رادیوتراپی در بیماران سرطانی قبل و بعد از مداخله در دهانشویه و ژل مخاط چسب حاوی بنزیدآمین. Timepoint: Follow-up will be conducted for 2 weeks and in 4 sessions (days 3, 5, 7 and 14). Method of measurement: WHO Mucositis Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-28</approval_date>
        <contact_name>Research Ethics Committee, Faculty of Dentistry, Shahid Sadoughi University of Medical Sciences, Yaz</contact_name>
        <contact_address>Deha Fajr Boulevard, Imam Reza Street, Faculty of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd1 Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
